IBA inks Saudi Arabian contract

TriMed Staff | | Health Imaging | Practice Management
Dec. 5 – Ion Beam Applications (IBA) has sold a Cyclone 30 to the King Faisal Specialist Hospital and Research Center, in Riyadh, Saudi Arabia, for the production of imaging radioisotopes.

According to the Louvain-La-Neuve, Belgium-based company, the cyclotron, fitted with three external beam lines, will be used to produce SPECT radioisotopes such as Thallium-201 and Iodine-123 and PET radioisotopes such as Fluoride-18. Production will be operational in 2009, said IBA, to supply the Saudi Arabia and neighboring Middle East countries with the radioisotopes.

In addition to equipment supply, IBA will also provide complete site engineering support for the integration of other production equipment, such as Technetium-99 generator production line, and detailed design of production laboratories according to the latest good manufacturing practices standards.

TriMed Staff

Related Content

Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups
Not all lead glasses are created equal

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.